When is it Time to Kill Your Drug? Maybe Sooner Than You Think
Patients stand to lose the most when sponsors hold too tightly to drugs doomed to fail. This wastes precious time that patients don’t have and squanders valuable resources.
Any Cancer Can Be a 'Rare Cancer'
With more common cancers now increasingly broken down by specific genomic defects, the future of research for any cancer is entirely, and unequivocally, molecular.